Danaher Corporation is reportedly close to finalizing a deal to acquire U.S. medical technology company Masimo for approximately $10 billion. Bloomberg posted on X, citing unnamed sources familiar with the negotiations. The acquisition would expand Danaher's portfolio in the healthcare sector, aligning with its strategic focus on medical technology. The deal is expected to enhance Danaher's capabilities in patient monitoring and healthcare solutions, though official confirmation from either company is yet to be announced. The move reflects ongoing consolidation trends within the medical technology industry, as companies seek to strengthen their market positions through strategic acquisitions.